Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Evidence of oxidative stress and mitochondrial dysfunction in spinocerebellar ataxia type 2 (SCA2) patient fibroblasts: Effect of coenzyme Q10 supplementation on these parameters

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Mitochondrial dysfunction induced by variation in the non-coding genome - A proposed workflow to improve diagnostics

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Growth and differentiation factor 15 as a biomarker for mitochondrial myopathy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Muscle contractility of leg muscles in patients with mitochondrial myopathies

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Melanopsin-expressing retinal ganglion cells are resistant to cell injury, but not always

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Mitochondrial dysfunction underlying outer retinal diseases

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. Paroxysmal Cranial Dyskinesia and Nail-Patella Syndrome Caused by a Novel Variant in the LMX1B Gene

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Expansion of the phenotypic spectrum of de novo missense variants in kinesin family member 1A (KIF1A)

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Spinocerebellar ataxia type 2 (SCA2) is a rare neurodegenerative disorder caused by a CAG repeat expansion in the ataxin-2 gene. We show increased oxidative stress, abnormalities in the antioxidant system, changes in complexes involved in oxidative phosphorylation and changes in mitochondrial morphology in SCA2 patient fibroblasts compared to controls, and we show that treatment with CoQ10 can partially reverse these changes. Together, our results suggest that oxidative stress and mitochondrial dysfunction may be contributory factors to the pathophysiology of SCA2 and that therapeutic strategies involving manipulation of the antioxidant system could prove to be of clinical benefit.

OriginalsprogEngelsk
TidsskriftMitochondrion
Vol/bind34
Sider (fra-til)103-114
Antal sider12
ISSN1567-7249
DOI
StatusUdgivet - maj 2017

ID: 51500866